Depending on the locale with the tumor, the mammillary and areola intricate can be preserved. Exactly the same also relates to prophylactic mastectomy (LoE 2a/GR B/In the past+). g., PARP inhibitor) to be a consequence of information on using PARP inhibitors in BRCA1/2 mutation carriers with